Unilabs

Unilabs is a leading international provider of diagnostic services, offering a comprehensive range of laboratory, pathology, genetics, and imaging services to patients across four continents. With a workforce of over 13,000 people, Unilabs leverages advanced digital technologies in its state-of-the-art laboratories and imaging institutes to improve the lives of nearly 100 million people annually.

Unilabs has strengthened its diagnostic capabilities through strategic acquisitions, such as ADUS Radiologie in December 2023, a radiology company with three centers in German-speaking Switzerland. This acquisition expanded Unilabs' radiology services to 18 locations in the region and 23 nationwide. Additionally, in November 2023, Unilabs officially completed its acquisition of Atalmedial, a leading provider of laboratory diagnostics and thrombosis care in the Netherlands, forming a robust organization specializing in these services across a substantial part of the country.

In November 2022, Unilabs acquired a majority stake in RIMED AG, a recognized Swiss diagnostic radiology group, strengthening its presence in German-speaking Switzerland and Ticino. The partnership aimed to simplify patient care through integrated IT solutions and optimized interdisciplinary data exchange. In December 2022, Unilabs acquired Proxilis, a diagnostics laboratory based in Geneva, to benefit from its local presence and expertise.

Key customers and partnerships

In April 2017, Unilabs collaborated with SOPHiA GENETICS to deploy the SOPHiA DDM Platform across Unilabs' network in Switzerland, which will test for HRD status in solid tumors and provide expedited analysis.

In April 2023, Unilabs partnered with SmartSoft healthcare to deploy the AI solution CoLumbo, enhancing lumbar spine MRI reading and reporting in Spain. This partnership aimed to improve the quality and efficiency of Unilabs' lumbar spine MRI exams, benefiting patients and radiologists. CoLumbo reduces reading and reporting time by up to 25% while improving diagnostic accuracy.

Unilabs has also invested in cutting-edge technology from Siemens Healthineers through a multi-year agreement valued at over EUR 200 million in February 2023. This collaboration involved acquiring over 400 laboratory analyzers to modernize Unilabs' laboratory infrastructure, improve customer service and quality, and enhance patient care.